Abstract:Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease that is the most common cause of dementia. Optogenetics uses a combination of genetic engineering and light to activate or inhibit specific neurons in the brain. Objective: The objective of the study was to examine the effect of activation of glutamatergic neurons in the hippocampus of mice injected with A beta 1-42 on memory function and biomarkers of neuroinflammation and neuroprotection in the brain to elucidate the clinical utility of optogenetic neuromodulation in AD. Methods: AAV5-CaMKII-channelrhodopsin-2 (CHR2)-mCherry (A beta-CHR2 mice) or AAV5-CaMKII-mCherry (A beta-non-CHR2 mice) was injected into the dentate gyrus (DG) of the bilateral hippocampus of an A beta 1-42-injected mouse model of AD. The novel object recognition test was used to investigate working memory (M1), short-term memory (M2), and long-term memory (M3) after A beta 1-42 injection. Hippocampus tissues were collected for immunohistochemical analysis. Results: Compared to controls, M1 and M2 were significantly higher in A beta-CHR2 mice, but there was no significant difference in M3; NeuN and synapsin expression were significantly increased in the DG of A beta-CHR2 mice, but not in CA1, CA3, the subventricular zone (SVZ), or the entorhinal cortex (ENT); GluR2 and IL-10 expressions were significantly increased, and GFAP expression was significantly decreased, in CA1, CA3, the DG, and the SVZ of A beta-CHR2 mice, but not in the ENT. Conclusion: Activation of glutamatergic neurons by optogenetics in the bilateral DG of an A beta-injected mouse model of AD improved M1 and M2, but not M3. A single-target optogenetics strategy has spatial limitations; therefore, a multiple targeted optogenetics approach to AD therapy should be explored.

Optogenetic manipulation of lysosomal physiology and autophagy-dependent clearance of amyloid beta

Optogenetic manipulation of lysosomal physiology and autophagic activity

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

Clearance of β-amyloid and synapses by the optogenetic depolarization of microglia is complement selective

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

Neuroprotective Effect of Optogenetics Varies With Distance From Channelrhodopsin-2 Expression in an Amyloid--Injected Mouse Model of Alzheimer's Disease

A Tauopathy-Homing and Autophagy-Activating Nanoassembly for Specific Clearance of Pathogenic Tau in Alzheimer's Disease.

Enhancement of Lysosome Biogenesis As a Potential Therapeutic Approach for Neurodegenerative Diseases.

Small molecule modulator of neuronal lysosome positioning and function resolves Alzheimers Disease-linked pathologies in cultured human neurons

Driving GABAergic neurons optogenetically improves learning, reduces amyloid load and enhances autophagy in a mouse model of Alzheimer's disease

Optogenetic Manipulation of Astrocytes from Synapses to Neuronal Networks: A Potential Therapeutic Strategy for Neurodegenerative Diseases

HLH-30/TFEB modulates autophagy to improve proteostasis in Aβ transgenic Caenorhabditis elegans

Nanomaterials-mediated lysosomal regulation: a robust protein-clearance approach for the treatment of Alzheimer’s disease

Neuronal lysosome transfer to oligodendrocyte precursor cells: a novel mechanism of neuron-glia communication and its role in neurodegenerative diseases

Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis

Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration

Regulation of neuroinflammation with GLP-1 receptor targeting nanostructures to alleviate Alzheimer’s symptoms in the disease models

Targeting Hsc70-based autophagy to eliminate amyloid β oligomers

Enhanced Autolysosomal Function Ameliorates the Inflammatory Response Mediated by the NLRP3 Inflammasome in Alzheimer’s Disease

Regulation of neuroinflammation with GLP-1 receptor targeting nanostructures to alleviate Alzheimer's symptoms in the disease models

Development of near-infrared lysosomal pH-activatable fluorescent probe for real-time visualization of autophagy progression